Global Immuno-Oncology Service Market Growth (Status and Outlook) 2026-2032
The global Immuno-Oncology Service market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Immuno-oncology describes the process of harnessing a patient's own immune system to fight cancer. Over the past decade, immuno-oncology has become an exciting cancer treatment approach due to its specificity, adaptability, and durability. Immuno-oncology services provide a one-stop platform to accelerate immuno-oncology research, including target selection, clinical trials, and monitoring and evaluation services.
United States market for Immuno-Oncology Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Immuno-Oncology Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Immuno-Oncology Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Immuno-Oncology Service players cover Crown Bioscience, Bio-Techne, Abcam, WuXi AppTec, Shanghai ChemPartner, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Immuno-Oncology Service Industry Forecast” looks at past sales and reviews total world Immuno-Oncology Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Immuno-Oncology Service sales for 2026 through 2032. With Immuno-Oncology Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno-Oncology Service industry.
This Insight Report provides a comprehensive analysis of the global Immuno-Oncology Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immuno-Oncology Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno-Oncology Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno-Oncology Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno-Oncology Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-Oncology Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
The report requires updating with new data and is sent in 48 hours after order is placed.
Immuno-oncology describes the process of harnessing a patient's own immune system to fight cancer. Over the past decade, immuno-oncology has become an exciting cancer treatment approach due to its specificity, adaptability, and durability. Immuno-oncology services provide a one-stop platform to accelerate immuno-oncology research, including target selection, clinical trials, and monitoring and evaluation services.
United States market for Immuno-Oncology Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Immuno-Oncology Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Immuno-Oncology Service is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Immuno-Oncology Service players cover Crown Bioscience, Bio-Techne, Abcam, WuXi AppTec, Shanghai ChemPartner, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Immuno-Oncology Service Industry Forecast” looks at past sales and reviews total world Immuno-Oncology Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Immuno-Oncology Service sales for 2026 through 2032. With Immuno-Oncology Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno-Oncology Service industry.
This Insight Report provides a comprehensive analysis of the global Immuno-Oncology Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immuno-Oncology Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno-Oncology Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno-Oncology Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno-Oncology Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-Oncology Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Basic Research
- Clinical Research
- Pharmaceutical Companies
- Medical Device Companies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Crown Bioscience
- Bio-Techne
- Abcam
- WuXi AppTec
- Shanghai ChemPartner
- George Clinical
- Laboratory Corporation of America® Holdings
- Medpace
- Genscript
- Shanghai Novamab Biopharmaceuticals
- LIDE
- TransCure bioServices
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immuno-Oncology Service Market Size (2021-2032)
2.1.2 Immuno-Oncology Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Immuno-Oncology Service by Country/Region (2021, 2025 & 2032)
2.2 Immuno-Oncology Service Segment by Type
2.2.1 Basic Research
2.2.2 Clinical Research
2.2.3 Immuno-Oncology Service Market Size by Type
2.2.3.1 Immuno-Oncology Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
2.3 Immuno-Oncology Service Segment by Application
2.3.1 Pharmaceutical Companies
2.3.2 Medical Device Companies
2.3.3 Other
2.3.4 Immuno-Oncology Service Market Size by Application
2.3.4.1 Immuno-Oncology Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
3 IMMUNO-ONCOLOGY SERVICE MARKET SIZE BY PLAYER
3.1 Immuno-Oncology Service Market Size Market Share by Player
3.1.1 Global Immuno-Oncology Service Revenue by Player (2021-2026)
3.1.2 Global Immuno-Oncology Service Revenue Market Share by Player (2021-2026)
3.2 Global Immuno-Oncology Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNO-ONCOLOGY SERVICE BY REGION
4.1 Immuno-Oncology Service Market Size by Region (2021-2026)
4.2 Global Immuno-Oncology Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Immuno-Oncology Service Market Size Growth (2021-2026)
4.4 APAC Immuno-Oncology Service Market Size Growth (2021-2026)
4.5 Europe Immuno-Oncology Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Immuno-Oncology Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Immuno-Oncology Service Market Size by Country (2021-2026)
5.2 Americas Immuno-Oncology Service Market Size by Type (2021-2026)
5.3 Americas Immuno-Oncology Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immuno-Oncology Service Market Size by Region (2021-2026)
6.2 APAC Immuno-Oncology Service Market Size by Type (2021-2026)
6.3 APAC Immuno-Oncology Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immuno-Oncology Service Market Size by Country (2021-2026)
7.2 Europe Immuno-Oncology Service Market Size by Type (2021-2026)
7.3 Europe Immuno-Oncology Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immuno-Oncology Service by Region (2021-2026)
8.2 Middle East & Africa Immuno-Oncology Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Immuno-Oncology Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNO-ONCOLOGY SERVICE MARKET FORECAST
10.1 Global Immuno-Oncology Service Forecast by Region (2027-2032)
10.1.1 Global Immuno-Oncology Service Forecast by Region (2027-2032)
10.1.2 Americas Immuno-Oncology Service Forecast
10.1.3 APAC Immuno-Oncology Service Forecast
10.1.4 Europe Immuno-Oncology Service Forecast
10.1.5 Middle East & Africa Immuno-Oncology Service Forecast
10.2 Americas Immuno-Oncology Service Forecast by Country (2027-2032)
10.2.1 United States Market Immuno-Oncology Service Forecast
10.2.2 Canada Market Immuno-Oncology Service Forecast
10.2.3 Mexico Market Immuno-Oncology Service Forecast
10.2.4 Brazil Market Immuno-Oncology Service Forecast
10.3 APAC Immuno-Oncology Service Forecast by Region (2027-2032)
10.3.1 China Immuno-Oncology Service Market Forecast
10.3.2 Japan Market Immuno-Oncology Service Forecast
10.3.3 Korea Market Immuno-Oncology Service Forecast
10.3.4 Southeast Asia Market Immuno-Oncology Service Forecast
10.3.5 India Market Immuno-Oncology Service Forecast
10.3.6 Australia Market Immuno-Oncology Service Forecast
10.4 Europe Immuno-Oncology Service Forecast by Country (2027-2032)
10.4.1 Germany Market Immuno-Oncology Service Forecast
10.4.2 France Market Immuno-Oncology Service Forecast
10.4.3 UK Market Immuno-Oncology Service Forecast
10.4.4 Italy Market Immuno-Oncology Service Forecast
10.4.5 Russia Market Immuno-Oncology Service Forecast
10.5 Middle East & Africa Immuno-Oncology Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Immuno-Oncology Service Forecast
10.5.2 South Africa Market Immuno-Oncology Service Forecast
10.5.3 Israel Market Immuno-Oncology Service Forecast
10.5.4 Turkey Market Immuno-Oncology Service Forecast
10.6 Global Immuno-Oncology Service Forecast by Type (2027-2032)
10.7 Global Immuno-Oncology Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Immuno-Oncology Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Information
11.1.2 Crown Bioscience Immuno-Oncology Service Product Offered
11.1.3 Crown Bioscience Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Crown Bioscience Main Business Overview
11.1.5 Crown Bioscience Latest Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Immuno-Oncology Service Product Offered
11.2.3 Bio-Techne Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bio-Techne Main Business Overview
11.2.5 Bio-Techne Latest Developments
11.3 Abcam
11.3.1 Abcam Company Information
11.3.2 Abcam Immuno-Oncology Service Product Offered
11.3.3 Abcam Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Abcam Main Business Overview
11.3.5 Abcam Latest Developments
11.4 WuXi AppTec
11.4.1 WuXi AppTec Company Information
11.4.2 WuXi AppTec Immuno-Oncology Service Product Offered
11.4.3 WuXi AppTec Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 WuXi AppTec Main Business Overview
11.4.5 WuXi AppTec Latest Developments
11.5 Shanghai ChemPartner
11.5.1 Shanghai ChemPartner Company Information
11.5.2 Shanghai ChemPartner Immuno-Oncology Service Product Offered
11.5.3 Shanghai ChemPartner Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Shanghai ChemPartner Main Business Overview
11.5.5 Shanghai ChemPartner Latest Developments
11.6 George Clinical
11.6.1 George Clinical Company Information
11.6.2 George Clinical Immuno-Oncology Service Product Offered
11.6.3 George Clinical Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 George Clinical Main Business Overview
11.6.5 George Clinical Latest Developments
11.7 Laboratory Corporation of America® Holdings
11.7.1 Laboratory Corporation of America® Holdings Company Information
11.7.2 Laboratory Corporation of America® Holdings Immuno-Oncology Service Product Offered
11.7.3 Laboratory Corporation of America® Holdings Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Laboratory Corporation of America® Holdings Main Business Overview
11.7.5 Laboratory Corporation of America® Holdings Latest Developments
11.8 Medpace
11.8.1 Medpace Company Information
11.8.2 Medpace Immuno-Oncology Service Product Offered
11.8.3 Medpace Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Medpace Main Business Overview
11.8.5 Medpace Latest Developments
11.9 Genscript
11.9.1 Genscript Company Information
11.9.2 Genscript Immuno-Oncology Service Product Offered
11.9.3 Genscript Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Genscript Main Business Overview
11.9.5 Genscript Latest Developments
11.10 Shanghai Novamab Biopharmaceuticals
11.10.1 Shanghai Novamab Biopharmaceuticals Company Information
11.10.2 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Product Offered
11.10.3 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Shanghai Novamab Biopharmaceuticals Main Business Overview
11.10.5 Shanghai Novamab Biopharmaceuticals Latest Developments
11.11 LIDE
11.11.1 LIDE Company Information
11.11.2 LIDE Immuno-Oncology Service Product Offered
11.11.3 LIDE Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 LIDE Main Business Overview
11.11.5 LIDE Latest Developments
11.12 TransCure bioServices
11.12.1 TransCure bioServices Company Information
11.12.2 TransCure bioServices Immuno-Oncology Service Product Offered
11.12.3 TransCure bioServices Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 TransCure bioServices Main Business Overview
11.12.5 TransCure bioServices Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immuno-Oncology Service Market Size (2021-2032)
2.1.2 Immuno-Oncology Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Immuno-Oncology Service by Country/Region (2021, 2025 & 2032)
2.2 Immuno-Oncology Service Segment by Type
2.2.1 Basic Research
2.2.2 Clinical Research
2.2.3 Immuno-Oncology Service Market Size by Type
2.2.3.1 Immuno-Oncology Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
2.3 Immuno-Oncology Service Segment by Application
2.3.1 Pharmaceutical Companies
2.3.2 Medical Device Companies
2.3.3 Other
2.3.4 Immuno-Oncology Service Market Size by Application
2.3.4.1 Immuno-Oncology Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
3 IMMUNO-ONCOLOGY SERVICE MARKET SIZE BY PLAYER
3.1 Immuno-Oncology Service Market Size Market Share by Player
3.1.1 Global Immuno-Oncology Service Revenue by Player (2021-2026)
3.1.2 Global Immuno-Oncology Service Revenue Market Share by Player (2021-2026)
3.2 Global Immuno-Oncology Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 IMMUNO-ONCOLOGY SERVICE BY REGION
4.1 Immuno-Oncology Service Market Size by Region (2021-2026)
4.2 Global Immuno-Oncology Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Immuno-Oncology Service Market Size Growth (2021-2026)
4.4 APAC Immuno-Oncology Service Market Size Growth (2021-2026)
4.5 Europe Immuno-Oncology Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Immuno-Oncology Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Immuno-Oncology Service Market Size by Country (2021-2026)
5.2 Americas Immuno-Oncology Service Market Size by Type (2021-2026)
5.3 Americas Immuno-Oncology Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immuno-Oncology Service Market Size by Region (2021-2026)
6.2 APAC Immuno-Oncology Service Market Size by Type (2021-2026)
6.3 APAC Immuno-Oncology Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Immuno-Oncology Service Market Size by Country (2021-2026)
7.2 Europe Immuno-Oncology Service Market Size by Type (2021-2026)
7.3 Europe Immuno-Oncology Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immuno-Oncology Service by Region (2021-2026)
8.2 Middle East & Africa Immuno-Oncology Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Immuno-Oncology Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL IMMUNO-ONCOLOGY SERVICE MARKET FORECAST
10.1 Global Immuno-Oncology Service Forecast by Region (2027-2032)
10.1.1 Global Immuno-Oncology Service Forecast by Region (2027-2032)
10.1.2 Americas Immuno-Oncology Service Forecast
10.1.3 APAC Immuno-Oncology Service Forecast
10.1.4 Europe Immuno-Oncology Service Forecast
10.1.5 Middle East & Africa Immuno-Oncology Service Forecast
10.2 Americas Immuno-Oncology Service Forecast by Country (2027-2032)
10.2.1 United States Market Immuno-Oncology Service Forecast
10.2.2 Canada Market Immuno-Oncology Service Forecast
10.2.3 Mexico Market Immuno-Oncology Service Forecast
10.2.4 Brazil Market Immuno-Oncology Service Forecast
10.3 APAC Immuno-Oncology Service Forecast by Region (2027-2032)
10.3.1 China Immuno-Oncology Service Market Forecast
10.3.2 Japan Market Immuno-Oncology Service Forecast
10.3.3 Korea Market Immuno-Oncology Service Forecast
10.3.4 Southeast Asia Market Immuno-Oncology Service Forecast
10.3.5 India Market Immuno-Oncology Service Forecast
10.3.6 Australia Market Immuno-Oncology Service Forecast
10.4 Europe Immuno-Oncology Service Forecast by Country (2027-2032)
10.4.1 Germany Market Immuno-Oncology Service Forecast
10.4.2 France Market Immuno-Oncology Service Forecast
10.4.3 UK Market Immuno-Oncology Service Forecast
10.4.4 Italy Market Immuno-Oncology Service Forecast
10.4.5 Russia Market Immuno-Oncology Service Forecast
10.5 Middle East & Africa Immuno-Oncology Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Immuno-Oncology Service Forecast
10.5.2 South Africa Market Immuno-Oncology Service Forecast
10.5.3 Israel Market Immuno-Oncology Service Forecast
10.5.4 Turkey Market Immuno-Oncology Service Forecast
10.6 Global Immuno-Oncology Service Forecast by Type (2027-2032)
10.7 Global Immuno-Oncology Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Immuno-Oncology Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Information
11.1.2 Crown Bioscience Immuno-Oncology Service Product Offered
11.1.3 Crown Bioscience Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Crown Bioscience Main Business Overview
11.1.5 Crown Bioscience Latest Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Immuno-Oncology Service Product Offered
11.2.3 Bio-Techne Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bio-Techne Main Business Overview
11.2.5 Bio-Techne Latest Developments
11.3 Abcam
11.3.1 Abcam Company Information
11.3.2 Abcam Immuno-Oncology Service Product Offered
11.3.3 Abcam Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Abcam Main Business Overview
11.3.5 Abcam Latest Developments
11.4 WuXi AppTec
11.4.1 WuXi AppTec Company Information
11.4.2 WuXi AppTec Immuno-Oncology Service Product Offered
11.4.3 WuXi AppTec Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 WuXi AppTec Main Business Overview
11.4.5 WuXi AppTec Latest Developments
11.5 Shanghai ChemPartner
11.5.1 Shanghai ChemPartner Company Information
11.5.2 Shanghai ChemPartner Immuno-Oncology Service Product Offered
11.5.3 Shanghai ChemPartner Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Shanghai ChemPartner Main Business Overview
11.5.5 Shanghai ChemPartner Latest Developments
11.6 George Clinical
11.6.1 George Clinical Company Information
11.6.2 George Clinical Immuno-Oncology Service Product Offered
11.6.3 George Clinical Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 George Clinical Main Business Overview
11.6.5 George Clinical Latest Developments
11.7 Laboratory Corporation of America® Holdings
11.7.1 Laboratory Corporation of America® Holdings Company Information
11.7.2 Laboratory Corporation of America® Holdings Immuno-Oncology Service Product Offered
11.7.3 Laboratory Corporation of America® Holdings Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Laboratory Corporation of America® Holdings Main Business Overview
11.7.5 Laboratory Corporation of America® Holdings Latest Developments
11.8 Medpace
11.8.1 Medpace Company Information
11.8.2 Medpace Immuno-Oncology Service Product Offered
11.8.3 Medpace Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Medpace Main Business Overview
11.8.5 Medpace Latest Developments
11.9 Genscript
11.9.1 Genscript Company Information
11.9.2 Genscript Immuno-Oncology Service Product Offered
11.9.3 Genscript Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Genscript Main Business Overview
11.9.5 Genscript Latest Developments
11.10 Shanghai Novamab Biopharmaceuticals
11.10.1 Shanghai Novamab Biopharmaceuticals Company Information
11.10.2 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Product Offered
11.10.3 Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Shanghai Novamab Biopharmaceuticals Main Business Overview
11.10.5 Shanghai Novamab Biopharmaceuticals Latest Developments
11.11 LIDE
11.11.1 LIDE Company Information
11.11.2 LIDE Immuno-Oncology Service Product Offered
11.11.3 LIDE Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 LIDE Main Business Overview
11.11.5 LIDE Latest Developments
11.12 TransCure bioServices
11.12.1 TransCure bioServices Company Information
11.12.2 TransCure bioServices Immuno-Oncology Service Product Offered
11.12.3 TransCure bioServices Immuno-Oncology Service Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 TransCure bioServices Main Business Overview
11.12.5 TransCure bioServices Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immuno-Oncology Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Immuno-Oncology Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Basic Research
Table 4. Major Players of Clinical Research
Table 5. Immuno-Oncology Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Immuno-Oncology Service Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
Table 8. Immuno-Oncology Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Immuno-Oncology Service Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
Table 11. Global Immuno-Oncology Service Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Immuno-Oncology Service Revenue Market Share by Player (2021-2026)
Table 13. Immuno-Oncology Service Key Players Head office and Products Offered
Table 14. Immuno-Oncology Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Immuno-Oncology Service Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Immuno-Oncology Service Market Size Market Share by Region (2021-2026)
Table 19. Global Immuno-Oncology Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Immuno-Oncology Service Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Immuno-Oncology Service Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Immuno-Oncology Service Market Size Market Share by Country (2021-2026)
Table 23. Americas Immuno-Oncology Service Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
Table 25. Americas Immuno-Oncology Service Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
Table 27. APAC Immuno-Oncology Service Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Immuno-Oncology Service Market Size Market Share by Region (2021-2026)
Table 29. APAC Immuno-Oncology Service Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Immuno-Oncology Service Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Immuno-Oncology Service Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Immuno-Oncology Service Market Size Market Share by Country (2021-2026)
Table 33. Europe Immuno-Oncology Service Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Immuno-Oncology Service Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Immuno-Oncology Service Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Immuno-Oncology Service Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Immuno-Oncology Service Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Immuno-Oncology Service
Table 39. Key Market Challenges & Risks of Immuno-Oncology Service
Table 40. Key Industry Trends of Immuno-Oncology Service
Table 41. Global Immuno-Oncology Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Immuno-Oncology Service Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Immuno-Oncology Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Immuno-Oncology Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Crown Bioscience Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 46. Crown Bioscience Immuno-Oncology Service Product Offered
Table 47. Crown Bioscience Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Crown Bioscience Main Business
Table 49. Crown Bioscience Latest Developments
Table 50. Bio-Techne Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 51. Bio-Techne Immuno-Oncology Service Product Offered
Table 52. Bio-Techne Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bio-Techne Main Business
Table 54. Bio-Techne Latest Developments
Table 55. Abcam Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 56. Abcam Immuno-Oncology Service Product Offered
Table 57. Abcam Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Abcam Main Business
Table 59. Abcam Latest Developments
Table 60. WuXi AppTec Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 61. WuXi AppTec Immuno-Oncology Service Product Offered
Table 62. WuXi AppTec Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. WuXi AppTec Main Business
Table 64. WuXi AppTec Latest Developments
Table 65. Shanghai ChemPartner Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 66. Shanghai ChemPartner Immuno-Oncology Service Product Offered
Table 67. Shanghai ChemPartner Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Shanghai ChemPartner Main Business
Table 69. Shanghai ChemPartner Latest Developments
Table 70. George Clinical Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 71. George Clinical Immuno-Oncology Service Product Offered
Table 72. George Clinical Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. George Clinical Main Business
Table 74. George Clinical Latest Developments
Table 75. Laboratory Corporation of America® Holdings Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 76. Laboratory Corporation of America® Holdings Immuno-Oncology Service Product Offered
Table 77. Laboratory Corporation of America® Holdings Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Laboratory Corporation of America® Holdings Main Business
Table 79. Laboratory Corporation of America® Holdings Latest Developments
Table 80. Medpace Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 81. Medpace Immuno-Oncology Service Product Offered
Table 82. Medpace Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Medpace Main Business
Table 84. Medpace Latest Developments
Table 85. Genscript Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 86. Genscript Immuno-Oncology Service Product Offered
Table 87. Genscript Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Genscript Main Business
Table 89. Genscript Latest Developments
Table 90. Shanghai Novamab Biopharmaceuticals Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 91. Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Product Offered
Table 92. Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Shanghai Novamab Biopharmaceuticals Main Business
Table 94. Shanghai Novamab Biopharmaceuticals Latest Developments
Table 95. LIDE Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 96. LIDE Immuno-Oncology Service Product Offered
Table 97. LIDE Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. LIDE Main Business
Table 99. LIDE Latest Developments
Table 100. TransCure bioServices Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 101. TransCure bioServices Immuno-Oncology Service Product Offered
Table 102. TransCure bioServices Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. TransCure bioServices Main Business
Table 104. TransCure bioServices Latest Developments
Table 1. Immuno-Oncology Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Immuno-Oncology Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Basic Research
Table 4. Major Players of Clinical Research
Table 5. Immuno-Oncology Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Immuno-Oncology Service Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
Table 8. Immuno-Oncology Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Immuno-Oncology Service Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
Table 11. Global Immuno-Oncology Service Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Immuno-Oncology Service Revenue Market Share by Player (2021-2026)
Table 13. Immuno-Oncology Service Key Players Head office and Products Offered
Table 14. Immuno-Oncology Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Immuno-Oncology Service Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Immuno-Oncology Service Market Size Market Share by Region (2021-2026)
Table 19. Global Immuno-Oncology Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Immuno-Oncology Service Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Immuno-Oncology Service Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Immuno-Oncology Service Market Size Market Share by Country (2021-2026)
Table 23. Americas Immuno-Oncology Service Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
Table 25. Americas Immuno-Oncology Service Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
Table 27. APAC Immuno-Oncology Service Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Immuno-Oncology Service Market Size Market Share by Region (2021-2026)
Table 29. APAC Immuno-Oncology Service Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Immuno-Oncology Service Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Immuno-Oncology Service Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Immuno-Oncology Service Market Size Market Share by Country (2021-2026)
Table 33. Europe Immuno-Oncology Service Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Immuno-Oncology Service Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Immuno-Oncology Service Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Immuno-Oncology Service Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Immuno-Oncology Service Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Immuno-Oncology Service
Table 39. Key Market Challenges & Risks of Immuno-Oncology Service
Table 40. Key Industry Trends of Immuno-Oncology Service
Table 41. Global Immuno-Oncology Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Immuno-Oncology Service Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Immuno-Oncology Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Immuno-Oncology Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Crown Bioscience Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 46. Crown Bioscience Immuno-Oncology Service Product Offered
Table 47. Crown Bioscience Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Crown Bioscience Main Business
Table 49. Crown Bioscience Latest Developments
Table 50. Bio-Techne Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 51. Bio-Techne Immuno-Oncology Service Product Offered
Table 52. Bio-Techne Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bio-Techne Main Business
Table 54. Bio-Techne Latest Developments
Table 55. Abcam Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 56. Abcam Immuno-Oncology Service Product Offered
Table 57. Abcam Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Abcam Main Business
Table 59. Abcam Latest Developments
Table 60. WuXi AppTec Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 61. WuXi AppTec Immuno-Oncology Service Product Offered
Table 62. WuXi AppTec Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. WuXi AppTec Main Business
Table 64. WuXi AppTec Latest Developments
Table 65. Shanghai ChemPartner Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 66. Shanghai ChemPartner Immuno-Oncology Service Product Offered
Table 67. Shanghai ChemPartner Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Shanghai ChemPartner Main Business
Table 69. Shanghai ChemPartner Latest Developments
Table 70. George Clinical Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 71. George Clinical Immuno-Oncology Service Product Offered
Table 72. George Clinical Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. George Clinical Main Business
Table 74. George Clinical Latest Developments
Table 75. Laboratory Corporation of America® Holdings Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 76. Laboratory Corporation of America® Holdings Immuno-Oncology Service Product Offered
Table 77. Laboratory Corporation of America® Holdings Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Laboratory Corporation of America® Holdings Main Business
Table 79. Laboratory Corporation of America® Holdings Latest Developments
Table 80. Medpace Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 81. Medpace Immuno-Oncology Service Product Offered
Table 82. Medpace Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Medpace Main Business
Table 84. Medpace Latest Developments
Table 85. Genscript Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 86. Genscript Immuno-Oncology Service Product Offered
Table 87. Genscript Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Genscript Main Business
Table 89. Genscript Latest Developments
Table 90. Shanghai Novamab Biopharmaceuticals Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 91. Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Product Offered
Table 92. Shanghai Novamab Biopharmaceuticals Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Shanghai Novamab Biopharmaceuticals Main Business
Table 94. Shanghai Novamab Biopharmaceuticals Latest Developments
Table 95. LIDE Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 96. LIDE Immuno-Oncology Service Product Offered
Table 97. LIDE Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. LIDE Main Business
Table 99. LIDE Latest Developments
Table 100. TransCure bioServices Details, Company Type, Immuno-Oncology Service Area Served and Its Competitors
Table 101. TransCure bioServices Immuno-Oncology Service Product Offered
Table 102. TransCure bioServices Immuno-Oncology Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. TransCure bioServices Main Business
Table 104. TransCure bioServices Latest Developments
LIST OF FIGURES
Figure 1. Immuno-Oncology Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-Oncology Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Immuno-Oncology Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Immuno-Oncology Service Sales Market Share by Country/Region (2025)
Figure 8. Immuno-Oncology Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Immuno-Oncology Service Market Size Market Share by Type in 2025
Figure 10. Immuno-Oncology Service in Pharmaceutical Companies
Figure 11. Global Immuno-Oncology Service Market: Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 12. Immuno-Oncology Service in Medical Device Companies
Figure 13. Global Immuno-Oncology Service Market: Medical Device Companies (2021-2026) & ($ millions)
Figure 14. Immuno-Oncology Service in Other
Figure 15. Global Immuno-Oncology Service Market: Other (2021-2026) & ($ millions)
Figure 16. Global Immuno-Oncology Service Market Size Market Share by Application in 2025
Figure 17. Global Immuno-Oncology Service Revenue Market Share by Player in 2025
Figure 18. Global Immuno-Oncology Service Market Size Market Share by Region (2021-2026)
Figure 19. Americas Immuno-Oncology Service Market Size 2021-2026 ($ millions)
Figure 20. APAC Immuno-Oncology Service Market Size 2021-2026 ($ millions)
Figure 21. Europe Immuno-Oncology Service Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Immuno-Oncology Service Market Size 2021-2026 ($ millions)
Figure 23. Americas Immuno-Oncology Service Value Market Share by Country in 2025
Figure 24. United States Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Immuno-Oncology Service Market Size Market Share by Region in 2025
Figure 29. APAC Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
Figure 30. APAC Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
Figure 31. China Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 35. India Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Immuno-Oncology Service Market Size Market Share by Country in 2025
Figure 38. Europe Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
Figure 39. Europe Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
Figure 40. Germany Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 41. France Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Immuno-Oncology Service Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 54. APAC Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 55. Europe Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 57. United States Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 58. Canada Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 59. Mexico Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 60. Brazil Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 61. China Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 62. Japan Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 63. Korea Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 65. India Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 66. Australia Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 67. Germany Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 68. France Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 69. UK Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 70. Italy Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 71. Russia Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 72. Egypt Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 73. South Africa Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 74. Israel Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 75. Turkey Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 76. Global Immuno-Oncology Service Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Immuno-Oncology Service Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 1. Immuno-Oncology Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-Oncology Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Immuno-Oncology Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Immuno-Oncology Service Sales Market Share by Country/Region (2025)
Figure 8. Immuno-Oncology Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Immuno-Oncology Service Market Size Market Share by Type in 2025
Figure 10. Immuno-Oncology Service in Pharmaceutical Companies
Figure 11. Global Immuno-Oncology Service Market: Pharmaceutical Companies (2021-2026) & ($ millions)
Figure 12. Immuno-Oncology Service in Medical Device Companies
Figure 13. Global Immuno-Oncology Service Market: Medical Device Companies (2021-2026) & ($ millions)
Figure 14. Immuno-Oncology Service in Other
Figure 15. Global Immuno-Oncology Service Market: Other (2021-2026) & ($ millions)
Figure 16. Global Immuno-Oncology Service Market Size Market Share by Application in 2025
Figure 17. Global Immuno-Oncology Service Revenue Market Share by Player in 2025
Figure 18. Global Immuno-Oncology Service Market Size Market Share by Region (2021-2026)
Figure 19. Americas Immuno-Oncology Service Market Size 2021-2026 ($ millions)
Figure 20. APAC Immuno-Oncology Service Market Size 2021-2026 ($ millions)
Figure 21. Europe Immuno-Oncology Service Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Immuno-Oncology Service Market Size 2021-2026 ($ millions)
Figure 23. Americas Immuno-Oncology Service Value Market Share by Country in 2025
Figure 24. United States Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Immuno-Oncology Service Market Size Market Share by Region in 2025
Figure 29. APAC Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
Figure 30. APAC Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
Figure 31. China Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 35. India Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Immuno-Oncology Service Market Size Market Share by Country in 2025
Figure 38. Europe Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
Figure 39. Europe Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
Figure 40. Germany Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 41. France Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Immuno-Oncology Service Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Immuno-Oncology Service Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Immuno-Oncology Service Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Immuno-Oncology Service Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 54. APAC Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 55. Europe Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 57. United States Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 58. Canada Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 59. Mexico Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 60. Brazil Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 61. China Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 62. Japan Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 63. Korea Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 65. India Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 66. Australia Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 67. Germany Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 68. France Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 69. UK Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 70. Italy Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 71. Russia Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 72. Egypt Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 73. South Africa Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 74. Israel Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 75. Turkey Immuno-Oncology Service Market Size 2027-2032 ($ millions)
Figure 76. Global Immuno-Oncology Service Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Immuno-Oncology Service Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Immuno-Oncology Service Market Size 2027-2032 ($ millions)
